Synthetic cell-based artificial tissues to study T cell activation

Synthetic lymph nodes constructed from programmable synthetic cells offer a novel approach to enhancing adaptive T cell immunotherapy. By utilizing droplet-supported lipid bilayers, researchers can recreate the mechanical and biochemical environment of natural lymph nodes, which current polystyrene bead-based methods lack. These synthetic tissues self-assemble into hierarchical structures that allow for precise control over T cell activation and migration. Beyond simply increasing T cell quantity, this platform influences T cell quality, specifically promoting the expansion of regulatory T cell phenotypes. This capability provides a promising avenue for addressing autoimmune conditions where immune overactivity is a concern. By integrating biomechanical sensing and structural organization, this synthetic tissue model bridges the gap between simplified laboratory activation methods and the complex, physiologically relevant conditions required for more effective clinical outcomes.